Analysis of Future Health ESG Corp. (FHLTW)
Future Health ESG Corp. (FHLTW) has been showing some interesting price movements and technical indicators in the recent days. Here is a brief analysis based on the provided data:
1. Price Movement:
- The closing price has been fluctuating between 0.0397 and 0.0895 in the past few days, with the most recent closing price at 0.0592.
- The price has been quite volatile, with significant highs and lows.
2. Technical Indicators:
- RSI Indicator: The Relative Strength Index (RSI) values have been around 44 to 56, indicating a moderate level of momentum in the stock.
- MACD Indicator: The Moving Average Convergence Divergence (MACD) values have been fluctuating around 0, suggesting a balance between bullish and bearish signals.
- Moving Averages: The Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) have been close to each other, indicating a stable trend.
3. Overall:
- The stock seems to be consolidating after some volatile price movements.
- The technical indicators suggest a neutral to slightly bullish sentiment.
- Traders and investors may want to monitor the stock for further price developments before making any trading decisions.
Please note that this analysis is based on historical data and technical indicators, and it's essential to conduct thorough research and analysis before making any investment decisions.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous results, ending on February 27, 2025, were handled by the Transfer Agent. The results from January 31, 2025, were released after hours. The results from October 31, 2024, were not provided at the time. The results from August 1, 2024, showed an earnings per share (EPS) estimate of 1.32.
Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuations metrics, stock price summary, and dividends and splits information for a specific company.
Financials:
- Cash flow: Operating cash flow TTM is $110,563,000,320 and levered free cash flow TTM is $84,726,874,112.
- Balance sheet: Total cash MRQ is $67,150,000,128, total debt MRQ is $104,590,000,128, current ratio MRQ is 1.037, book value per share MRQ is $4.837, total cash per share MRQ is $4.379, and total debt to equity MRQ is 140.968.
- Profit margin: 26.306%
- Fiscal year ends: September 30, 2023
- Income statement: EBITDA is $131,393,000,000, revenue TTM is $381,623,009,280, diluted EPS TTM is $6.43, gross profit TTM is $169,148,000,000, revenue per share TTM is $24.537, net income to common TTM is $100,389,003,264, quarterly revenue growth is -4.3%, and quarterly earnings growth YoY is -2.2%.
- Operating margin: 30.743%
- Most recent quarter: March 31, 2024
- Return on assets TTM: 22.073999%
- Return on equity TTM: 147.25%
Stock statistics:
- Short ratio: 1.53
- Float shares: 15,308,320,742
- Shares short: 99,287,450
- Average 10-day volume: 46,860,048
- Average 90-day volume: 57,498,254
- Shares outstanding: 15,334,099,968
- Percent held by insiders: 5.22%
- Percent held by institutions: 57.589%
- Short percent of shares outstanding: 0.65%
Valuations metrics:
- PEG ratio: 26.319502
- Forward PE: 26.319502
- Trailing PE: 29.59409
- Enterprise value: $2,950,762,332,160
- Price to book MRQ: 39.3405
- Price to sales TTM: 7.646095
- Enterprise to EBITDA: 22.763
- Enterprise to revenue: 7.732
- Market capitalization: $2,917,925,650,432
Stock price summary:
- Beta: 1.264
- 50-day moving average: $176.2646
- 200-day moving average: $181.0429
- 52-week low: $164.08
- 52-week high: $199.62
- 52-week change: 6.853%
Dividends and splits:
- Payout ratio: 14.93%
- Dividend date: May 16, 2024
- Last split date: August 31, 2020
- Ex-dividend date: May 10, 2024
- Last split factor: 4-for-1 split
- Forward annual dividend rate: $1
- 5-year average dividend yield: 0.73%
- Forward annual dividend yield: 0.5255%
- Trailing annual dividend rate: $0.97
- Trailing annual dividend yield: 0.5097%
Income statement 💸
These are the revenues. Here are the conclusions:
1. The company's sales have been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. The gross profit margin has been fluctuating, with a peak in 2021 at $152.8 billion and a slight decrease in 2023 to $169.1 billion.
3. Operating income has shown an upward trend, reaching $114.3 billion in 2023 from $66.3 billion in 2020.
4. Net income has also been increasing consistently, with $57.4 billion in 2020 rising to $97 billion in 2023.
5. Earnings per share (EPS) have shown a slight variation but have generally been stable over the years.
6. The company has been able to maintain a healthy EBITDA margin, with $129.2 billion in 2023.
7. Despite fluctuations in other income and expenses, the company has managed to increase its net income from continuous operations over the years.
8. The company has been able to effectively manage its operating expenses, with a slight increase in selling, general, and administrative expenses over the years.
9. The company has been paying a consistent amount in income taxes, with fluctuations based on the profitability of the company each year.
10. The number of outstanding shares has remained relatively stable over the years, affecting metrics like EPS.
Balance Sheet
These are balance sheets. Here are the conclusions:
1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets include cash, inventory, and receivables, with a significant portion in cash equivalents and short-term investments.
3. Non-current assets consist mainly of investments and advances, along with machinery, furniture, and equipment.
4. Total liabilities have also been increasing, but at a slower pace compared to assets, indicating a healthy financial position.
5. Shareholders' equity has shown a positive trend, with a notable increase in retained earnings over the years.
6. The company has been managing its short-term and long-term debts effectively, as well as provisions for risks and charges.
7. Overall, the financial stability and growth of the company seem to be on a positive trajectory based on the balance sheet data.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:
1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with a focus on operational efficiency and strategic investments.
Earnings estimate
The analysts' estimates for future quarterly and annual earnings per share are as follows:
1. Current Quarter (as of June 30, 2024):
- Average Estimate: $1.33
- Low Estimate: $1.27
- High Estimate: $1.36
- Year Ago EPS: $1.26
- Number of Analysts: 26
2. Next Quarter (as of September 30, 2024):
- Average Estimate: $1.53
- Low Estimate: $1.44
- High Estimate: $1.63
- Year Ago EPS: $1.46
- Number of Analysts: 25
3. Current Year (as of September 30, 2024):
- Average Estimate: $6.59
- Low Estimate: $6.43
- High Estimate: $6.92
- Year Ago EPS: $6.13
- Number of Analysts: 39
4. Next Year (as of September 30, 2025):
- Average Estimate: $7.23
- Low Estimate: $6.40
- High Estimate: $7.90
- Year Ago EPS: $6.59
- Number of Analysts: 39
Based on these estimates, we can see a generally positive trend in the expected earnings per share for both the upcoming quarters and the next fiscal year. The average estimates show growth compared to the previous year's EPS figures, indicating a positive outlook from analysts regarding the company's performance.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:
1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with slightly higher growth expected in the next fiscal year compared to the current one.
Growth estimates
Based on the consensus estimates provided:
- The company is expected to experience a growth rate of 7.5% in the current year.
- The growth rate is projected to increase to 5.6% in the current quarter and further to 4.8% in the next quarter.
- Over the next year, the growth rate is expected to reach 9.7%.
- Looking ahead, the company is forecasted to achieve an annual growth rate of 11% over the next 5 years.
- However, when compared to the past 5 years where the company had a growth rate of 20.15% per annum, the future growth rate is expected to be lower.
These estimates suggest a positive outlook for the company's growth in the near future, although at a slightly lower rate compared to the past performance.
Price target
Based on the analysts' forecast, the future price of the security is expected to range between $164 (low) and $250 (high), with a median estimate of $200 and an average estimate of $202.26. The current price of the security is $191.57.MACD of FHLTW